Suppr超能文献

局部应用于鼻黏膜的羟甲唑啉可减少中耳的经黏膜氧化亚氮交换。

Oxymetazoline Applied Topically to the Nasal Mucosa Decreases Trans-Mucosal Nitrous Oxide Exchange for the Middle Ear.

作者信息

Teixeira Miriam S, Alper Cuneyt M, Martin Brian S, Helal Narmin, Doyle Brendan M Cullen, Doyle William J

机构信息

Department of Otolaryngology, School of Medicine of the University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Department of Otolaryngology, School of Medicine of the University of Pittsburgh, Pittsburgh, Pennsylvania, USA Department of Pediatric Otolaryngology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, USA.

出版信息

Ann Otol Rhinol Laryngol. 2016 May;125(5):400-7. doi: 10.1177/0003489415617776. Epub 2015 Nov 26.

Abstract

OBJECTIVE

Determine if the middle ear (ME) trans-mucosal nitrous oxide (N2O) gas exchange rate can be pharmacologically modulated by the nasal application of a vasoconstrictor.

METHODS

In a randomized, double-blind, crossover study, 20 adults received a nasal spray challenge containing either oxymetazoline or saline (placebo). At each session, subjects were fitted with a non-rebreathing mask and breathed room air for 20 minutes, 50% N2O:50% O2 for 20 minutes, and 100% O2 for 10 minutes. Throughout, heart rate, blood pressure (BP), and blood O2 saturation were monitored, and bilateral ME pressure was recorded by tympanometry every minute. The primary outcome measure was the slope of the ME pressure-time function for the experimental period, a direct measure of the transMEM N2O exchange constant. The effects of treatment, session, and period on the measured vital signs and of treatment, session, disease history, and ear on the ME pressure-time slopes were evaluated for statistical significance using repeated measures ANOVAs.

RESULTS

The analysis documented a significant effect of period on O2 saturation (N2O > room air, P = .03) and of treatment on blood pressure (oxymetazoline > placebo, P < .02) and the ME pressure-time slope (placebo > oxymetazoline, P = .05).

CONCLUSION

The exchange rate across the ME mucosa of inert gases can be decreased by topical treatment of the nasal mucosa with oxymetazoline.

摘要

目的

确定通过鼻腔应用血管收缩剂是否能对中耳(ME)跨黏膜一氧化二氮(N₂O)气体交换率进行药理学调节。

方法

在一项随机、双盲、交叉研究中,20名成年人接受了含有羟甲唑啉或生理盐水(安慰剂)的鼻腔喷雾激发试验。在每个试验阶段,受试者佩戴无重复呼吸面罩,先呼吸室内空气20分钟,再呼吸50% N₂O:50% O₂混合气体20分钟,最后呼吸100% O₂ 10分钟。在此过程中,监测心率、血压(BP)和血氧饱和度,并通过鼓室图每分钟记录双侧中耳压力。主要观察指标是试验期内中耳压力 - 时间函数的斜率,这是跨中耳黏膜N₂O交换常数的直接测量指标。使用重复测量方差分析评估治疗、试验阶段和时间段对所测生命体征的影响,以及治疗、试验阶段、病史和耳部情况对中耳压力 - 时间斜率的影响,以确定统计学意义。

结果

分析表明,时间段对血氧饱和度有显著影响(N₂O > 室内空气,P = 0.03),治疗对血压(羟甲唑啉 > 安慰剂,P < 0.02)和中耳压力 - 时间斜率(安慰剂 > 羟甲唑啉,P = 0.05)有显著影响。

结论

用羟甲唑啉局部治疗鼻黏膜可降低惰性气体跨中耳黏膜的交换率。

相似文献

1
Oxymetazoline Applied Topically to the Nasal Mucosa Decreases Trans-Mucosal Nitrous Oxide Exchange for the Middle Ear.
Ann Otol Rhinol Laryngol. 2016 May;125(5):400-7. doi: 10.1177/0003489415617776. Epub 2015 Nov 26.
2
Histamine Applied Topically to the Nasal Mucosa Increases the Transmucosal Nitrous Oxide Exchange for the Middle Ear.
Ann Otol Rhinol Laryngol. 2017 Apr;126(4):284-289. doi: 10.1177/0003489416689470. Epub 2017 Jan 19.
3
Oral pseudoephedrine decreases the rate of transmucosal nitrous oxide exchange for the middle ear.
Laryngoscope. 2015 Sep;125(9):2181-6. doi: 10.1002/lary.25221. Epub 2015 Jul 7.
4
Nasal prostaglandin challenge increases N2O exchange from blood to middle ear.
Auris Nasus Larynx. 2005 Mar;32(1):29-32. doi: 10.1016/j.anl.2004.11.008.
7
The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa.
Acta Otolaryngol. 1997 Nov;117(6):851-5. doi: 10.3109/00016489709114213.
8
The nasal airways response in normal subjects to oxymetazoline spray: randomized double-blind placebo-controlled trial.
Br J Clin Pharmacol. 1999 Jul;48(1):53-6. doi: 10.1046/j.1365-2125.1999.00972.x.
9
Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
Laryngoscope. 1996 May;106(5 Pt 1):605-9. doi: 10.1097/00005537-199605000-00016.
10
Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection.
Am J Rhinol. 1998 Mar-Apr;12(2):125-9. doi: 10.2500/105065898781390316.

引用本文的文献

1
A formal description of middle ear pressure-regulation.
Hear Res. 2017 Oct;354:73-85. doi: 10.1016/j.heares.2017.08.005. Epub 2017 Aug 24.
2
Histamine Applied Topically to the Nasal Mucosa Increases the Transmucosal Nitrous Oxide Exchange for the Middle Ear.
Ann Otol Rhinol Laryngol. 2017 Apr;126(4):284-289. doi: 10.1177/0003489416689470. Epub 2017 Jan 19.

本文引用的文献

1
Oral pseudoephedrine decreases the rate of transmucosal nitrous oxide exchange for the middle ear.
Laryngoscope. 2015 Sep;125(9):2181-6. doi: 10.1002/lary.25221. Epub 2015 Jul 7.
2
Interventions for adult Eustachian tube dysfunction: a systematic review.
Health Technol Assess. 2014 Jul;18(46):1-180, v-vi. doi: 10.3310/hta18460.
3
Pressure chamber tests of eustachian tube function document lower efficiency in adults with colds when compared to without colds.
Acta Otolaryngol. 2014 Jul;134(7):691-7. doi: 10.3109/00016489.2014.892213. Epub 2014 May 19.
4
Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.
Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Jun;130(3):137-44. doi: 10.1016/j.anorl.2012.09.005. Epub 2013 Feb 1.
5
Rationale and feasibility of intranasal delivery of drugs to the eustachian tube orifice.
Curr Allergy Asthma Rep. 2012 Dec;12(6):541-6. doi: 10.1007/s11882-012-0310-3.
6
A cross-sectional study of the change in mastoid geometry with age in children without a history of otitis media.
Laryngoscope. 2012 Mar;122(3):649-53. doi: 10.1002/lary.22500. Epub 2012 Jan 17.
7
Role of the mastoid in middle ear pressure regulation.
Laryngoscope. 2011 Feb;121(2):404-8. doi: 10.1002/lary.21275. Epub 2011 Jan 13.
8
Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace.
Am J Rhinol Allergy. 2010 Jul-Aug;24(4):249-54. doi: 10.2500/ajra.2010.24.3499.
9
The unified airway--conceptual framework.
Otolaryngol Clin North Am. 2008 Apr;41(2):257-66, v. doi: 10.1016/j.otc.2007.11.002.
10
The mastoid as a functional rate-limiter of middle ear pressure change.
Int J Pediatr Otorhinolaryngol. 2007 Mar;71(3):393-402. doi: 10.1016/j.ijporl.2006.11.004. Epub 2006 Dec 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验